CAP-XX Limited Spire Health Selects CAP-XX Supercapacitors
07 Septiembre 2021 - 1:00AM
RNS Non-Regulatory
TIDMCPX
CAP-XX Limited
07 September 2021
REACH
7 September 2021
CAP-XX Limited
("CAP-XX")
CAP-XX Supercaps Power Spire Health's Remote Respiratory
Monitoring for Patients with Chronic Respiratory Diseases
Supercapacitors handle peak power role to keep Spire Health
Tag's battery small and form factor thin
Sydney, Australia - September 7, 2021 - CAP-XX Limited
(LSE:CPX), the leading manufacturer of ultra-thin prismatic and
cylindrical supercapacitors, announced that Spire Health, the
leading provider of respiratory remote patient monitoring (RPM),
has selected the CAP-XX supercap to provide the peak power needed
to deliver respiratory and pulse rate monitoring for pulmonary
patients in the company's new Health Tag garment-adhered sensor.
The company's original Health Tags used CAP-XX supercapacitors to
deliver wellness alerts to consumers. The new Health Tag's core
focus is now healthcare, where the CAP-XX supercapacitors are used
to notify a patient's care team of changes in their health in an
effort to enable early interventions and prevent hospital
admissions.
Offloading the peak power role to the thin, flat supercapacitor
allows Spire to keep the battery small to achieve the ultra-thin
form factor of its wearable biosensor. The tag's 3V coin cell
battery continuously trickle charges the CAP-XX HA114T
supercapacitor (0.7mm thin, 120 millifarads, 130 milli-Ohms), which
then provides the pulses of 660mW to power LED pulse rate
notifications.
Spire Health Tags adhere to a patient's existing clothing, can
be washed and dried as normal, need no charging and last up to 12
months. The Health Tags use advanced algorithms and proprietary
respiratory sensors to continuously measure, with medical grade
accuracy, a patient's respiratory effort, pulse rate and activity.
This data is displayed on the patient's mobile app. Deviations from
clinical baselines are automatically detected and shared with the
patient's care team through the healthcare professional dashboard.
Changes in patient health are often detected many days before a
patient reports symptoms or experiences physiological decline.
The CAP-XX HA114T supercapacitor's features include:
-- 120 mF / 2.75 Volt
-- 20 x 20 x 0.7 mm
-- Very low Equivalent Series Resistance (ESR) of 130 m
-- Up to 10 year life
"Spire Health Tags are the only commercial solution for remote
long term, continuous monitoring of respiratory effort," said Phil
Golz, Vice President, Spire Health. "The 100% passive sensor
requires no interaction or engagement from patients, and research
has shown that our algorithms can detect subtle changes in
respiratory patterns days before patients are hospitalized due to
acute exacerbations. This is tremendously exciting for the future
of care for patients living with chronic respiratory
conditions."
"CAP-XX's thin, prismatic supercaps address the size, weight and
cost challenges of designing thin, sometimes disposable electronic
IoT devices like wearables and portables," said Alex Bilyk, VP,
Research and Development at CAP-XX. "They help IoT device
manufacturers add peak-power features, extend battery life, avoid
oversized batteries, or even replace batteries when paired with an
energy harvester."
For further information contact:
CAP-XX Limited
Anthony Kongats (CEO) +61 (0) 2 9428 0139
Kreab (Financial PR)
Robert Speed +44 (0) 20 7074 1800
Allenby Capital (Nominated Adviser
and Joint Broker)
David Hart / Alex Brearley (Corporate
Finance)
Tony Quirke (Sales and Corporate
Broking) +44 (0) 20 3328 5656
Cenkos Securities plc (Joint Broker)
Neil McDonald / Pete Lynch +44 (0) 13 1220 6939
About CAP-XX
CAP-XX (LSE:CPX) is a world leader in the design and manufacture
of ultra-thin prismatic and compact cylindrical supercapacitors.
Its prismatic supercapacitors are manufactured in Australia and
Malaysia and its cylindrical supercapacitors are manufactured in
China. The company's strong intellectual property (IP) portfolio
includes 21 patents worldwide. CAP-XX's ultra-thin prismatic
supercapacitors are ideal for space-constrained electronics
applications where small energy storage device size and thickness
are important. The unique feature of CAP-XX supercapacitors is
their very high-power density and high-energy storage capacity in
space-efficient thin prismatic and compact cylindrical packages.
For more information about CAP-XX, visit https://www.cap-xx.com/ or
email sales@cap-xx.com.
About Spire Health
Spire Health is the leading digital healthcare company for
continuous respiratory monitoring and actionable feedback. The
Spire Health Tag enables remote patient monitoring with
unparalleled adherence and clinical-grade accuracy. Spire Health's
remote patient monitoring approach has the potential to identify
and predict health events, enable early interventions, and prevent
hospital admissions. Spire is backed by leading medical health
investors and has received a grant from the US Department of Health
and Human Services. For more information visit: www.spirehealth.com
.
About Reach announcements
This is a Reach announcement. Reach is an investor communication
service aimed at assisting listed and unlisted (including AIM
quoted) companies to distribute media only / non-regulatory news
releases into the public domain. Information required to be
notified under the AIM Rules for Companies, Market Abuse Regulation
or other regulation would be disseminated as an RNS regulatory
announcement and not on Reach.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAFZGGLMVDGMZM
(END) Dow Jones Newswires
September 07, 2021 02:00 ET (06:00 GMT)
Cap-xx (LSE:CPX)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Cap-xx (LSE:CPX)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024